PRISM BioLab is committed to maximizing the potential of its PepMetics™ Technology, transforming the “undruggable” to “druggable” with the aim of finding cures for the incurable.
PRISM BioLab is a biotechnology company with PepMetics Technology, a proprietary drug discovery platform. PepMetics Molecules are designed to mimic α-helix or β-turn peptides using unique, stable scaffolds.
Company Details
- Employees
- 17
- Founded
- 2006
- Address
- 26-1, Muraoka-Higashi 2-Chome, Fujisawa Shi,kanagawa 251-8555,japan
- Industry
- Biotechnology
- Website
- https://prismbiolab.com/
- Keywords
- 藤沢市.
- HQ
- Fujisawa shi, Kanagawa
Prism Biolab Co., Ltd. Questions
Prism Biolab Co., Ltd.'s website is https://prismbiolab.com/
Prism Biolab Co., Ltd.'s LinkedIn profile is https://jp.linkedin.com/company/prismbiolab-co-ltd
Prism Biolab Co., Ltd. has
17 employees.
View email and phone details for 17
employees at Prism Biolab Co., Ltd..
Prism Biolab Co., Ltd.'s industry is
Biotechnology
Prism Biolab Co., Ltd.'s top competitors are
Shonan Health Innovation Park,
Fimecs, Inc.,
Axcelead Drug Discovery Partners, Inc.,
Chugai Pharmaceutical Co., Ltd.,
Prism Biotech, Inc.,
Locus Biosciences, Inc.,
Takeda,
Myrobalan Therapeutics,
Kyowa Kirin Co., Ltd.,
Aptatargets.
Prism Biolab Co., Ltd.'s categories are Biotechnology
Prism Biolab Co., Ltd.'s founding year is 2006
